Dr. David Carmouche, Lumeris: Why AI Is Primary Care's Best Chance at Survival
In this episode, Christina Farr talks with Dr. David Carmouche, Chief Medical and Commercial Officer at Lumeris, about the crisis in primary care and how AI could be its lifeline. Carmouche explains that rising administrative burdens, outdated fee‑for‑service payment models, and patient consumerism have eroded the traditional doctor‑patient relationship, leaving PCPs overwhelmed and patients disengaged. He argues that autonomous AI—combined with new payment structures that reward outcomes rather than visits—could enable a single primary‑care physician to effectively manage thousands of patients, restoring efficiency and joy to the profession. Carmouche also highlights ongoing federal and state experiments, such as CMS’s Access Model and state sandbox initiatives, that are testing these innovative payment and care‑delivery frameworks.
Can Healthcare Claims Be Adjudicated in Real-Time? W/ Don Peterson, Founder & CEO, PIM Health
In this episode, Don Peterson, founder of PIM Health, explains how the current U.S. healthcare payment system creates massive administrative overhead and cash‑flow delays for providers, largely because insurers profit from the float on claims. He outlines PIM’s solution: real‑time...
Heidi Health’s Kos Says Shadow AI Signals a Tool Gap CIOs Can’t Ignore
In this episode, Dr. Simon Koss, CMO of Heidi Health, explains how AI scribe technology has transformed clinical decision support, moving from pre‑AI tools that caused alert fatigue and required clinicians to hunt for information, to generative AI that can...
Toward Clinical-Grade AI: Shaping the Healthcare Experience
In this Technovation episode, leaders from Stanford Healthcare and HCA Healthcare discuss how AI is moving the industry from mere digitization to truly digital, clinical-grade applications. Michael Pfeffer highlights AI’s ability to predict disease states and augment physician decision‑making, while...
Who Controls Medical AI and What Do They Want?
In this episode, Dr. Eric Topol discusses the promise and pitfalls of medical AI, highlighting how nearly 1,000 FDA‑approved AI tools exist but are rarely used in routine care, while millions turn to unregulated chatbots for health advice. He explains...
Schneck’s Rice: Clinician Scoring, Independence Drove Meditech Expanse Pick Over Epic
In this episode, Schneck Medical Center CIO Craig Rice discusses the unique challenges of rural healthcare, especially tight margins and the need for disciplined technology investments. He explains how Schneck evaluated EMR options, ultimately choosing Meditech Expanse over Epic and...
Forget the Search for a Single AI ROI Number, Say Akhter and Chou — Build Coalitions, Scale What Works
In this episode, Children’s Hospital of Philadelphia’s SVP, Chief Digital and Information Officer Shaqib Octor and veteran health‑IT executive David Chow discuss how health systems are grappling with defining AI ROI. They argue that ROI isn’t just a dollar figure—it...
Why Price Transparency Took a Decade to Crack | Heather Fernandez, Solv
In this episode, Heather Fernandez, CEO of Solve, discusses the decade‑long struggle to achieve price transparency in U.S. healthcare and how her company is finally cracking the "how much will it cost me?" question using AI-driven ClearPay. She traces her...
Anthropic + Gates Give $200M to Healthcare | Cerebras IPO Doubles
The episode covers several major AI developments: the Gates Foundation and Anthropic each pledged $200 million over four years to deploy Claude in global health, education, life‑sciences and economic mobility, focusing on low‑resource regions; Cerebras Systems priced its IPO at $185...
How Your Body Data Could Reshape Sectors
In this episode, Morgan Stanley health‑care analyst Erin Wright discusses the rise of the self‑directed patient, highlighting how direct‑to‑consumer lab tests and wearables are shifting health care from reactive treatment to proactive prevention. She notes that U.S. chronic disease costs...
Diagnosing the Future: Proteins, Biosensors and Fundamental Science with Prof. Eleonora Macchia
In this episode, Prof. Eleonora Macchia discusses how fundamental research on protein interactions can be turned into ultra‑sensitive biosensors for early disease detection, highlighting her ERC project that moved from studying topological transitions of proteins to a clinical trial for pancreatic...
University of Utah Health’s Kawamoto Says Workbench Approach Scales Clinical AI Across the Enterprise
Dr. Ken Kawamoto, University of Utah Health’s Chief Health AI Transformation Officer, discusses how his team is scaling clinical AI across the enterprise using a standards‑based AI Workbench that plugs into the Epic EHR. He explains the evolution of his...
Why Healthcare Costs Keep Climbing
In this brief episode, Dr. Pearl discusses how generative AI can empower patients and clinicians by providing instant, personalized health insights before a doctor's visit, illustrated with a real‑world example of a skier diagnosing a rotator cuff tear via ChatGPT....
The AI Paradox: Why LLMs in Healthcare Actually Require More Structured Data, Not Less | Ewout Kramer & Ward Weistra...
In this episode, Awad Kramer and Ward Weistra of Firely discuss the origins and evolution of FHIR Dev Days, a community‑driven conference that educates developers on implementing the FHIR standard. They highlight how FHIR has become the backbone of health‑IT...
Building Maven Clinic when No One Believed with CEO Kate Ryder
In this episode of Lifers, CEO Kate Ryder discusses the evolution of Maven Clinic, the first unicorn in women's health, focusing on the challenges of scaling from $200M to $500M in revenue and aligning every part of the business. She...